Two doctors sent to jail for propagating sex determination tests
By Press Trust of India,
Press Trust of India
| 11. 02. 2009
Two doctors were awarded three years imprisonment by a local court here for propagating sex determination tests, banned under Pre-conception and Pre-natal Diagnostic Techniques (prohibition of sex selection) Act.
Dr Chhaya Tated, a homoeopath from Aurangabad and Dr Shubhangi Adkar, who runs a private maternity and nursing home at Dadar here, were recently found guilty of violating the Act, in a case filed against them five years back.
Dr Tated had published an advertisement offering "special treatment to those who wanted a baby (boy)". She used to come to nursing home of Dr Adkar to practice twice in a month.
Both the doctors pleaded leniency but the court turned their plea saying although they were respectable members of the society, they had committed a serious crime.
The magistrate RV Jambkar held, "When such persons commit offences that are not only heinous but against the existence of the society. They are not entitled to leniency, because by their act, they have encouraged determination of sex of a female foetus to prevent such pregnancy".
The complaint against them was filed in November...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...
